FI883589A - Process for Preparation of Unsaturated Amino Acid Compounds - Google Patents

Process for Preparation of Unsaturated Amino Acid Compounds Download PDF

Info

Publication number
FI883589A
FI883589A FI883589A FI883589A FI883589A FI 883589 A FI883589 A FI 883589A FI 883589 A FI883589 A FI 883589A FI 883589 A FI883589 A FI 883589A FI 883589 A FI883589 A FI 883589A
Authority
FI
Finland
Prior art keywords
preparation
amino acid
acid compounds
unsaturated amino
unsaturated
Prior art date
Application number
FI883589A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI883589A0 (en
FI94415B (en
FI94415C (en
Inventor
Hans Allgeier
Christof Angst
Guido Bold
Rudolf Duthaler
Roland Heckendorn
Antonio Togni
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI883589A0 publication Critical patent/FI883589A0/en
Publication of FI883589A publication Critical patent/FI883589A/en
Publication of FI94415B publication Critical patent/FI94415B/en
Application granted granted Critical
Publication of FI94415C publication Critical patent/FI94415C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/16Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165Esters of thiophosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/48Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof
    • C07F9/4808Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof the acid moiety containing a substituent or structure which is considered as characteristic
    • C07F9/4825Acyclic unsaturated acids or derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/302Acyclic unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826Acyclic unsaturated acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI883589A 1987-08-04 1988-08-01 Process for the preparation of unsaturated amino acid compounds FI94415C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH298687 1987-08-04
CH298687 1987-08-04

Publications (4)

Publication Number Publication Date
FI883589A0 FI883589A0 (en) 1988-08-01
FI883589A true FI883589A (en) 1989-02-05
FI94415B FI94415B (en) 1995-05-31
FI94415C FI94415C (en) 1995-09-11

Family

ID=4246086

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883589A FI94415C (en) 1987-08-04 1988-08-01 Process for the preparation of unsaturated amino acid compounds

Country Status (16)

Country Link
EP (1) EP0302826A3 (en)
JP (2) JP2714018B2 (en)
KR (1) KR970011164B1 (en)
AU (1) AU605340B2 (en)
CA (1) CA1328113C (en)
DD (1) DD282016A5 (en)
DK (1) DK434788A (en)
FI (1) FI94415C (en)
HU (1) HU202242B (en)
IL (1) IL87246A (en)
NO (1) NO172495C (en)
NZ (1) NZ225649A (en)
PH (1) PH27591A (en)
PT (1) PT88170B (en)
YU (1) YU150188A (en)
ZA (1) ZA885653B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175344A (en) * 1986-02-13 1992-12-29 Ciba-Geigy Corporation Unsaturated amino acids
DK0391850T3 (en) * 1989-04-07 1994-10-24 Ciba Geigy Ag Unsaturated aminodicarboxylic acid derivatives
EP0420806B1 (en) * 1989-09-26 1995-07-05 Ciba-Geigy Ag Phosphonic acids, process for preparation and use as an active pharmaceutical composition
US5488140A (en) * 1989-09-26 1996-01-30 Ciba-Geigy Corporation 4-substituted 2-aminoalk-3-enoic
US5294734A (en) * 1989-09-26 1994-03-15 Ciba-Geigy Corp. 4-substituted 2-aminoalk-3-enoic acids
US7414086B2 (en) 2005-05-13 2008-08-19 Shin-Etsu Chemical Co., Ltd. Room temperature-curable organopolysiloxane compositions
AU2006310177A1 (en) * 2005-10-18 2007-05-10 Centre National De La Recherche Scientifique (Cnrs) Hypophosphorous acid derivatives and their therapeutical applications
JP4952952B2 (en) 2008-09-12 2012-06-13 信越化学工業株式会社 Method for producing room temperature curable organopolysiloxane composition
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0233154B1 (en) * 1986-02-13 1991-12-18 Ciba-Geigy Ag Unsaturated amino-acids

Also Published As

Publication number Publication date
DD282016A5 (en) 1990-08-29
AU2038988A (en) 1989-03-02
EP0302826A2 (en) 1989-02-08
FI883589A0 (en) 1988-08-01
KR970011164B1 (en) 1997-07-08
PT88170B (en) 1995-03-01
PT88170A (en) 1989-06-30
FI94415B (en) 1995-05-31
NO172495C (en) 1993-07-28
JPH0248586A (en) 1990-02-19
YU150188A (en) 1990-04-30
NO883444L (en) 1989-02-06
KR890003786A (en) 1989-04-18
JP2714018B2 (en) 1998-02-16
IL87246A0 (en) 1989-03-31
HU202242B (en) 1991-02-28
JPH1053597A (en) 1998-02-24
CA1328113C (en) 1994-03-29
NO172495B (en) 1993-04-19
FI94415C (en) 1995-09-11
DK434788D0 (en) 1988-08-03
EP0302826A3 (en) 1991-04-03
PH27591A (en) 1993-08-31
AU605340B2 (en) 1991-01-10
DK434788A (en) 1989-02-05
IL87246A (en) 1996-07-23
NZ225649A (en) 1991-05-28
HUT47947A (en) 1989-04-28
NO883444D0 (en) 1988-08-03
ZA885653B (en) 1989-04-26

Similar Documents

Publication Publication Date Title
PT87754A (en) PROCESS FOR THE PREPARATION OF NEW AMINO ACID DERIVATIVES
FI882638A0 (en) Process for the preparation of therapeutically useful boro amino acid derivatives
FI892881A0 (en) Process for the preparation of therapeutically useful amino acid derivatives
FI882007A (en) Process for the preparation of steroid-5-reductase inhibitors
FI860484A (en) Process for the preparation of therapeutically active peptide compounds
FI883064A (en) Process for the preparation of therapeutically useful heterocyclic compounds
DE3366919D1 (en) Bicyclic amino acid derivatives, process for their preparation, agents containing them and their application, bicyclic amino acids as intermediates, and process for their preparation
FI90769C (en) Process for the preparation of therapeutically useful triazole compounds
PT87153A (en) PROCESS FOR THE PREPARATION OF ACID RIBOFURANURONIC DERIVATIVES
FI881303A0 (en) Process for the preparation of ibuprofen
FI883997A (en) Process for the preparation of therapeutically useful substituted 2-phenyl-4-quinolinecarboxylic acids
FI884471A0 (en) Process for the preparation of therapeutically active dihydropyridine compounds
FI93215C (en) Process for the preparation of therapeutically useful aminoalkoxyphenyl derivatives
FI883589A (en) Process for Preparation of Unsaturated Amino Acid Compounds
PT88545A (en) PROCESS FOR THE MANUFACTURE OF BENZIMIDAZOLINE-2-OXO-1-CARBOXYLIC ACID DERIVATIVE COMPOUNDS
PT87857A (en) PROCESS FOR THE PREPARATION OF NOVEL IMMUNOSSUPRESSANT PEPTIDES
FI92188C (en) Process for the preparation of therapeutically useful phenoxyalkylpyrocatechol derivatives
FI89062C (en) Process for the preparation of therapeutically useful somatostatin alloys
FI885045A (en) Process for Preparation of Polynucleotides
FI863282A0 (en) New Process for Preparation of Methylenedioxyphenanthrene Compounds
FI90658C (en) Process for the preparation of therapeutically useful (E) -2- (p-fluorophenethyl) -3-fluoroallylamine
HRP940444A2 (en) Process for the preparation of unsaturated amino acid compounds
FI933175A0 (en) Process for Preparation of Optically Active -arylalkanecarboxylic Acids
EG18418A (en) Process for the preparation of novel 2-thienyloxacetic acid derivatives
NO180296C (en) Process for the preparation of cyclic amino acid compounds

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MM Patent lapsed
MM Patent lapsed

Owner name: NOVARTIS AG